NCT00041093View on ClinicalTrials.gov

Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

October 23, 2006

Conditions
Cervical Squamous Cell Carcinoma, Not Otherwise SpecifiedRecurrent Cervical Carcinoma
Interventions
DRUG

Docetaxel

Given IV

Trial Locations (1)

19103

Gynecologic Oncology Group, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00041093 - Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer | Biotech Hunter | Biotech Hunter